Shandong Boan Biotechnology Co (FRA:UJ9) Operating Margin %: -0.12% (As of Dec. 2025)


FRA:UJ9 Shandong Boan Biotechnology Co Ltd FRA:UJ9
39 GF Score
Price €0.51
GF Value €1.68
! 5 Warning Signs
View Full Analysis

What is Shandong Boan Biotechnology Co Operating Margin %?

Shandong Boan Biotechnology Co FRA:UJ9 +1.41% 39 Operating Margin % is -0.12% as of Dec. 2025. GuruFocus rates FRA:UJ9 with a GF Score™ of 39/100 and a GF Value™ of €1.68. The stock has 5 warning signs investors should review. Among 944 Biotechnology companies, Shandong Boan Biotechnology Co ranks better than 75.64% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Shandong Boan Biotechnology Co's Operating Income for the six months ended in Dec. 2025 was €-0.06 Mil. Shandong Boan Biotechnology Co's Revenue for the six months ended in Dec. 2025 was €47.46 Mil. Therefore, Shandong Boan Biotechnology Co's Operating Margin % for the quarter that ended in Dec. 2025 was -0.12%.

The historical rank and industry rank for Shandong Boan Biotechnology Co's Operating Margin % or its related term are showing as below:

FRA:UJ9' s Operating Margin % Range Over the Past 10 Years
Min: -136.73   Med: -16.85   Max: 14.39
Current: 5.14


FRA:UJ9's Operating Margin % is ranked better than
75.64% of 944 companies
in the Biotechnology industry
Industry Median: -86.83 vs FRA:UJ9: 5.14

Shandong Boan Biotechnology Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Shandong Boan Biotechnology Co's Operating Income for the six months ended in Dec. 2025 was €-0.06 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €4.90 Mil.

Warning Sign:

Shandong Boan Biotechnology Co Ltd has recorded a loss in operating income at least once over the past 3 years.


Shandong Boan Biotechnology Co  (FRA:UJ9) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Shandong Boan Biotechnology Co Operating Margin % Related Terms


Shandong Boan Biotechnology Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for Shandong Boan Biotechnology Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Boan Biotechnology Co Operating Margin % Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial -136.73 -63.23 -16.85 14.39 5.17

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.05 10.55 18.22 10.43 -0.12

FRA:UJ9 vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Boan Biotechnology Co Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's Operating Margin % falls into.


FRA:UJ9
39GF Score
Shandong Boan Biotechnology Co Ltd FRA:UJ9
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Boan Biotechnology Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Shandong Boan Biotechnology Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=4.919 / 95.161
=5.17 %

Shandong Boan Biotechnology Co's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-0.057 / 47.459
=-0.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -0.12% mean?
Shandong Boan Biotechnology Co (FRA:UJ9) has a Operating Margin % of -0.12% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Shandong Boan Biotechnology Co and its competitors. According to the industry distribution chart, Shandong Boan Biotechnology Co ranks #230 out of 944 companies in the Biotechnology industry, placing it in the top 24.4%.
Is Shandong Boan Biotechnology Co's Operating Margin % too high?
Shandong Boan Biotechnology Co's current Operating Margin % is -0.12%. Based on the distribution chart, Shandong Boan Biotechnology Co ranks #230 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Boan Biotechnology Co has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Boan Biotechnology Co's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shandong Boan Biotechnology Co ranks #230 out of 944 companies for Operating Margin %. This places Shandong Boan Biotechnology Co in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Shandong Boan Biotechnology Co and its competitors. Shandong Boan Biotechnology Co's current Operating Margin % is -0.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Boan Biotechnology Co stock overvalued right now?
Shandong Boan Biotechnology Co (FRA:UJ9) has a current Operating Margin % of -0.12%. The stock's GF Value™ is €1.68, compared to a current price of €0.51 — trading 69.9% below its estimated fair value. The current Operating Margin % is -0.12%. Shandong Boan Biotechnology Co's overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Shandong Boan Biotechnology Co (FRA:UJ9), the current Operating Margin % is -0.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Boan Biotechnology Co (FRA:UJ9) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Boan Biotechnology Co stock appears to be undervalued. The current stock price of €0.51 is trading 69.9% below its estimated GF Value™ of €1.68.

Key valuation signals for FRA:UJ9:

  • Operating Margin %: -0.12%
  • GF Value™: €1.68 vs. price of €0.51 (69.9% below fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the FRA:UJ9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Boan Biotechnology Co Business Description

Other Exchanges 06955:Hong Kong
Address No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. It is focused on developing, manufacturing, and marketing biologics, with a focus on oncology, autoimmune diseases, ophthalmology, and metabolic diseases. The company's drug discovery activities revolve around multiple platforms: Fully Human Antibody Platform, bsAb/msAb/Probody Platform, and ADC Platform. It has commercialized several products, such as Boyounuo, Boyoubei (denosumab injection 60 mg), Boluojia (denosumab injection 120 mg), Boyouping (dulaglutide injection), and Boyoujing; and is actively engaged in the development of other drugs like BA1104 (nivolumab injection), BA1106, BA1302 (an anti-CD228 ADC), etc. Geographically, the company generates maximum revenue from the Chinese mainland.
39GF Score

Get the complete analysis for FRA:UJ9

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.51
Price
€1.68
GF Value